CureMatch
PrivateLast Round
VC Round
Jun 1, 2021
Total Funding Raised
$45,000
Company Overview
CureMatch operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a VC Round in June 2021.
CureMatch is a digital health company that provides a decision support system to guide oncologists in the selection of personalized cancer drug combinations based on a patient's molecular tumor profile.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureMatch Comparables
Compare CureMatch with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenomOncology | 82% | |
| Clarified Precision Medicine | 81% | |
| OncoDNA | 81% |
For institutional investors. Book with your work email.
CureMatch Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 1, 2021 | ||||
| Grant | Jun 14, 2018 | ||||
| Grant | Aug 18, 2017 | ||||
| Seed | Aug 15, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CureMatch Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Analytics Ventures | Seed |
| World Trade Center San Diego MetroConnect | Grant |
| Unitleader | VC Round |
| JPMorgan Chase & Co. | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2021
Raised a VC Round with Unitleader as an investor.
- Jun 14, 2018
$35K grant received from JPMorgan Chase and World Trade Center San Diego.
For institutional investors. Book with your work email.
CureMatch Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CureMatch's valuation, stock price, and market status.
Is CureMatch a public or private company?
CureMatch is a private company.
What is the current stock price of CureMatch?
CureMatch is a private company, so its shares have no public market price. Caplight tracks CureMatch's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CureMatch worth (valuation)?
Valuation information for CureMatch is not publicly available.
Can I buy CureMatch stock?
CureMatch shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CureMatch's last funding round?
CureMatch's most recent funding round was VC Round on June 1, 2021.
Who are the main investors in CureMatch?
Key investors in CureMatch include Analytics Ventures, World Trade Center San Diego MetroConnect, Unitleader, JPMorgan Chase & Co..
Will CureMatch IPO soon?
No public IPO plans have been announced for CureMatch.
How can I track CureMatch secondary market activity?
Caplight tracks bids, offers, and trades in CureMatch's shares on secondary markets.